Parkinson Disease

The AJMC® Parkinson Disease compendium is a comprehensive resource for clinical news and expert insights for progressive nervous system disorder, which affects movement and often includes tremors.

Improved Motor Function Achieved With High- vs Low-Dose Inhaled Levodopa in PD

August 1st 2022, 5:18pm


Significantly more patients with Parkinson disease (PD) achieved improved motor function and clinical outcomes when treated with high- vs low-dose inhaled levodopa.

Greater Cerebrospinal Fluid Protein Levels May Accelerate Progression of Parkinson Disease

July 26th 2022, 7:40pm


Faster motor and cognitive progression of Parkinson disease was found in patients with higher baseline cerebrospinal fluid neurofilament heavy levels.

Angiotensin Receptor Blockers May Reduce PD Risk in Patients With Hypertension

July 22nd 2022, 3:00pm


Angiotensin receptor blockers exhibited potential neuroprotective properties for reducing Parkinson disease (PD) risk in patients with newly diagnosed hypertension.

Stakeholders List 6 Actionable Steps to Ameliorate Global Disparities in Parkinson Disease

July 11th 2022, 8:25pm


Advocacy and awareness; prevention and risk reduction; diagnosis, treatment, and care; caregiver support; and research were listed as actionable steps that are urgently needed to address global disparities in Parkinson disease.

Sensory Stimulation, Physical Therapy Effective at Improving Gait Performance in PD

July 8th 2022, 5:05pm


Electrical stimulation, physical activity, and balance interventions were also found to be effective in improving gait for patients with neurological disorders including Parkinson disease (PD), stroke, and dementia, according to a recent review.

Parkinson Disease Monitoring App Available for Apple Watch

June 27th 2022, 8:11pm


Rune Labs’ StrivePD software has been granted FDA clearance to collect data for patients with Parkinson disease using the Apple Watch, supporting communication of data between clinicians and patients.

Inhaled Levodopa Product Launches in Germany

June 20th 2022, 5:18pm


The product, sold as Inbrija, is commercialized in Germany through an agreement with Esteve Pharmaceuticals GmbH.

Plasma IGF-1 Could Be Important Parkinson Disease Biomarker

June 16th 2022, 4:17pm


Levels of the hormone increase with disease severity, a new study has found.

Frequent Nightmares in Older Men May Signal Later PD, Study Says

June 11th 2022, 2:07am


A new study suggests that men who have disturbing dreams more than once a week have a risk that is more than twice as high as the population of developing Parkinson disease (PD).

Genetic Risk Scores for Alzheimer Disease May Have Implications for Parkinson Disease

May 30th 2022, 7:27pm


The findings from the study indicate that higher genetic risk score for Alzheimer disease (AD) are associated with cognitive declines in patients with Parkinson disease (PD), while higher genetic risk scores for PD signify an increased risk of PD, albeit with slower clinical progression after diagnosis.